Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001050362 | SCV001214464 | pathogenic | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Leu1324Serfs*4) in the EYS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EYS are known to be pathogenic (PMID: 18836446, 20333770). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with EYS-related conditions. ClinVar contains an entry for this variant (Variation ID: 846934). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002505595 | SCV002812156 | likely pathogenic | Retinitis pigmentosa 25 | 2022-02-04 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV002505595 | SCV004193519 | likely pathogenic | Retinitis pigmentosa 25 | 2023-12-06 | criteria provided, single submitter | clinical testing |